ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.

INMB INmune Bio Inc

11.29
0.45 (4.15%)
Apr 26 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
INmune Bio Inc INMB NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
0.45 4.15% 11.29 19:00:00
Open Price Low Price High Price Close Price Previous Close
10.83 10.83 11.73 11.29 10.84
more quote information »

Recent News

Date Time Source Heading
4/25/202408:00GLOBEINmune Bio Inc. Announces $9.7 Million Registered Direct..
4/23/202407:00GLOBEINmune Bio Inc. Announces 24-Month Stability Validation of..
4/22/202407:00GLOBEINmune Bio Inc. Raises Approximately $4.8 Million in Gross..
4/08/202407:00GLOBEINmune Bio Inc. Presents Data on INB03’s Role as an Immune..
3/28/202415:01GLOBEINmune Bio Inc. Announces Year End 2023 Results and Provides..
3/26/202415:01GLOBEINmune Bio Inc. to Report Fourth Quarter 2023 Financial..
3/13/202407:00GLOBEINmune Bio CSO and Co-Founder Mark Lowdell, Ph.D. Receives..
3/05/202407:00GLOBEINmune Bio Reports Significant EEG Improvement in..
2/12/202408:00GLOBEINmune Bio to Participate in the Oppenheimer 34th Annual..
2/06/202408:00GLOBEINmune Bio to Participate in Baird’s Biotech Discovery..
1/30/202407:02EDGAR2Form 8-K - Current report
1/30/202407:00GLOBEINmune Bio Announces FDA Removal of Clinical Hold for..
1/16/202407:30GLOBEELEVAI Labs, Inc. Acquires Worldwide License Agreement for..
1/02/202415:00EDGAR2Form 8-K - Current report
1/02/202407:00GLOBEINmune Bio Announces First Patient Dosed in a Phase 1/2..
12/18/202315:15EDGAR2Form 8-K - Current report
12/18/202315:05EDGAR2Form 8-A12B/A - Registration of securities [Section 12(b)]:..
12/18/202315:01EDGAR2Form 8-K - Current report
12/18/202315:01GLOBEINmune Bio Provides Update Regarding Global Alzheimer’s..
11/29/202315:00EDGAR2Form 8-K - Current report
11/29/202307:00GLOBEINmune Bio Inc. Demonstrates that INB03 Enhances the Uptake..
11/27/202315:00EDGAR2Form 8-K - Current report
11/27/202307:00GLOBEINmune Bio Receives EMA’s Authorization in France and Spain..
11/15/202315:13EDGAR2Form 8-K - Current report
11/15/202308:00GLOBEINmune Bio Inc. Announces Expansion of Phase II Clinical..
11/13/202310:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/01/202315:13EDGAR2Form 8-K - Current report
11/01/202315:10GLOBEINmune Bio Inc. Announces Third Quarter 2023 Results and..
11/01/202315:05EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
10/31/202315:25EDGAR2Form 8-K - Current report
10/31/202307:00GLOBEINmune Bio Inc. Patent Claims Covering INB16 Cell Line and..
10/30/202308:07GLOBEINmune Bio Inc. Presents Preclinical Data at SITC 2023..
10/17/202307:00GLOBEINmune Bio Inc. Presents New Biomarker and Feasibility Data..
10/16/202308:00GLOBEINmune Bio Inc. to Report Third Quarter 2023 Financial..
9/07/202308:10EDGAR2Form 8-K - Current report
9/07/202308:00GLOBEINmune Bio Inc. to Present at Baird Global Healthcare..
9/05/202315:00EDGAR2Form 8-K - Current report
9/05/202307:00GLOBEINmune Bio Inc. Announces Approval of Clinical Trial..
8/16/202315:41EDGAR2Form 8-K - Current report
8/16/202315:39EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
8/08/202315:01EDGAR2Form 8-K - Current report
8/07/202315:05EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
8/07/202315:00GLOBEINmune Bio Inc. Announces Second Quarter 2023 Results and..
8/02/202305:02EDGAR2Form 8-K - Current report
8/01/202307:00GLOBEINmune Bio Inc. to Present at the BTIG Virtual ..
7/31/202307:00GLOBEINmune Bio, Inc. to Report Second Quarter 2023 Financial..
7/27/202315:43EDGAR2Form 8-K - Current report
7/14/202315:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
7/12/202315:00EDGAR2Form 8-K - Current report
7/12/202312:23EDGAR2Form 144 - Report of proposed sale of securities

Your Recent History

Delayed Upgrade Clock